About 100 reports

  • Revenue Share (%), by Business Segment, 2017

It is one of the world' s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.

  • Chemotherapy
  • United States
  • Amgen Inc.
  • AstraZeneca PLC
  • Merck & Co., Inc.

Develops drugs for oncology, bone and joint diseases, central nervous system (CNS) disorders, and autoimmune diseases.

  • Chemotherapy
  • World
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Pfizer Inc.

Kaposi sarcoma induced due to HIV/ AIDS is one of the most common causes of the disease and acts as a major driver for the market.

  • Chemotherapy
  • Forecast
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

While oncology has been one of the most active therapeutic areas for drug development, for drugmakers the new cancer drugs have proven far more difficult to gain approval than medicines for infectious and autoimmune diseases.

  • Chemotherapy
  • World
  • Astellas Pharma Inc.
  • Medivation, Inc.
  • PROVENGE group

Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group

Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.

  • Chemotherapy
  • China
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Beijing Novartis Pharma Ltd

Many of the immunosuppressive drugs used in the treatment of autoimmune diseases such as corticosteroids, and organ transplant rejection (cyclosporine, tacrolimus) work by inhibiting the production of IL-## by antigen-activated T cells.

  • Chemotherapy
  • China
  • Demand
  • Trade
  • Hainan Haiyao Company Limited

Many of the immunosuppressive drugs used in the treatment of autoimmune diseases such as corticosteroids, and organ transplant rejection (cyclosporine, tacrolimus) work by inhibiting the production of IL-## by antigen-activated T cells.

  • Chemotherapy
  • China
  • Demand
  • Market Size
  • Trade

Genes & Diseases; ##(##): ##-## Cancer Network.

  • Chemotherapy
  • World
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.

Many of the immunosuppressive drugs used in the treatment of autoimmune diseases such as corticosteroids, and organ transplant rejection (cyclosporine, tacrolimus) work by inhibiting the production of IL-## by antigen-activated T cells.

  • Chemotherapy
  • China
  • Demand
  • Novartis AG
  • Sanofi-Synthelabo Inc.

Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.

  • Chemotherapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd

Roche is the world leader in in-vitro diagnostics and drugs for cancer Page## Chapter VII SKIN CANCER TREATMENT DRUGS PRODUCER DIRECTORY and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metaboli

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.

Many of the immunosuppressive drugs used in the treatment of autoimmune diseases such as corticosteroids, and organ transplant rejection (cyclosporine, tacrolimus) work by inhibiting the production of IL-## by antigen-activated T cells.

  • Chemotherapy
  • China
  • Demand
  • Trade
  • Sanofi-Synthelabo Inc.

Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group

Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.

  • Chemotherapy
  • China
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group
  • Shenzhen Main Luck Pharmaceuticals Inc.

(USA) ##.

  • Cancer
  • Chemotherapy
  • United States
  • World
  • Market Shares

THIS STUDY INCLUDED BOTH PD-L## NEGATIVE TWO WEEKS) OR DOCETAXEL (##MG/ M (##%) AND PD-L## POSITIVE (##%) PATIENTS, BUT EXCLUDED PATIENTS WITH AUTOIMMUNE DISEASE, SYMPTOMATIC ILD, AND UNTREATED BRAIN METASTASIS.

  • Chemotherapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.

Drivers and their Impact Driver Hospitals Pharmaceutical Stores Increase in Prevalence of Breast Cancer Low Low Unmet Medical Needs ## ## ## ## ## High High Low Low ## ## ## ## ## High High Increase in Prevalence of Breast Cancer Americas Low Low ## ## ## ## ## High High Low Low

  • Chemotherapy
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Hoffmann-La Roche Inc.
  • BRISTOL-MYERS SQUIBB: KEY TAKEAWAYS
  • MARKET SHARE ANALYSIS 2014

The company develops drugs, using the genomic antibody drug discovery approach, in the areas of oncology, bone and joint diseases, CNS disorders, autoimmune diseases, and others.

  • Chemotherapy
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Investigators Information

Has a known additional malignancy that is progressing or requires active treatment Has known active central nervous system metastases and/ or carcinomatous meningitis Has an active autoimmune disease requiring systemic treatment within the past ## months or a documented history

  • Chemotherapy
  • Therapy
  • United States
  • World
  • Nerviano Medical Sciences Srl

It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and neurological diseases.

  • Chemotherapy
  • General Medicine And Specialty Medicine
  • United States
  • World
  • Product Initiative

One is a phase I trial vorinostat with intravenous temsirolimus for patients with metastatic disease.

  • Chemotherapy
  • Oncology
  • United States
  • World
  • Acetylon Pharmaceuticals, Inc.
  • PIPELINE BY MIMIVAX LLC, H1 2018

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2018 Summary Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Baculoviral inhibitor of apoptosis repeat-containing...

  • Chemotherapy
  • Hospital
  • Oncology
  • Therapy
  • Immunovaccine Inc.

Some of the common autoimmune diseases include celiac disease, diabetes mellitus Type ##, Graves' disease, inflammatory bowel disease, multiple sclerosis, psoriasis, rheumatoid arthritis, and systemic lupus erythematosus.

  • Chemotherapy
  • United States
  • Company
  • Market Size
  • Bristol-Myers Squibb Company

Medimmune undertake research in the areas of cancer treatment; respiratory; inflammation and autoimmune; and cardiovascular disorders and metabolic diseases.

  • Blood Disease
  • Chemotherapy
  • Vaccine
  • United States
  • Merck & Co., Inc.

Genentech is one of the leading biotechnology companies in the US.

  • Chemotherapy
  • Therapy
  • United States
  • Company
  • Genentech, Inc.
  • target action, date of April 3, 2018.

Only ## patient had progressive disease.

  • Chemotherapy
  • Hospital
  • Therapy
  • United States
  • Product Initiative
  • KEYTRUDA versus investigator-choice chemotherapy (paclitaxel, docetaxel, vinflunine) (HR, 0.73 [95 percent CI, 0.59, 0.91], p equal to 0.002).

Immune-mediated adverse events were autoimmune hemolytic anemia (n=##), colitis (n=##), hypothyroidism (n=##), and hypothyroidism (n=##).

  • Cancer
  • Chemotherapy
  • Therapy
  • United States
  • Product Initiative

The company' s pipeline is used for treating multiple sclerosis, dysfunctional B cells, autoimmune diseases, breast cancer and other cancers.

  • Chemotherapy
  • United States
  • World
  • Product Initiative
  • Coherus BioSciences, Inc.

It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and neurological diseases.

  • Chemotherapy
  • North America
  • United States
  • Company
  • Product Initiative